SAMPLE - hfhs-formslibrary.orghfhs-formslibrary.org/forms/WBC-75-0320-0411 antibiotic... ·...

2
West Bloomfield Hospital Antibiotic Susceptibility Report 2010 Department of Pathology and Laboratory Medicine West Bloomfield Hospital Pathology Department – Microbiology Division, Antibiotic Susceptibility Report W. Bloomfield Laboratory Dr. Bruce Jones, MD, Medical Director, 248-325-0509 Debbie Chapman, Operations Manager, 248-325-0508 Microbiology Division Linoj Samuel, PhD, D(ABMM) , Division Head, 313-916-2341 Robert Tibbetts, PhD, Associate Director, 313-916-9381 Rhonda Hensley, MT(ASCP), Manager, 313-916-1745 Gerald B. Russell, RM(AAM), Leader, Serology/Virology, 313-916-1045 Lucy Avellano, MT(ASCP), Leader, Afternoon Service, 313-916-1041 The Inpatient and Outpatient Antibiotic susceptibility reports and trended data a re available online at the Henry intranet webs ite (http//henry.hfhs.org). Type “Antibiograms” in the Search box, then click “go” and follow the link to the Microbiology Division webpage hosting the antibiograms. Links to the reports are on the right side of the page. The reports are posted in PDF format and can be downloaded to your PDA. Downloading instructions are available from the Sladen library webpage . Antibiogram data is for West Bloomfield Hospital use only. Do not print this data except for your own use. Inquiries by pharmaceutical sales representatives or others should be directed to Pharmacy. Pharmacy will release data when appropriate. Form #: WBC-75-0320-0411rev West Bloomfield Hospital Antibiotic Susceptibility Report 2010 Department of Pathology and Laboratory Medicine West Bloomfield Hospital Pathology Department – Microbiology Division, Antibiotic Susceptibility Report W. Bloomfield Laboratory Dr. Bruce Jones, MD, Medical Director, 248-325-0509 Debbie Chapman, Operations Manager, 248-325-0508 Microbiology Division Linoj Samuel, PhD, D(ABMM), Division Head, 313-916-2341 Robert Tibbetts, PhD, Associate Director, 313-916-9381 Rhonda Hensley, MT(ASCP), Manager, 313-916-1745 Gerald B. Russell, RM(AAM), Leader, Serology/Virology, 313-916-1045 Lucy Avellano, MT(ASCP), Leader, Afternoon Service, 313-916-1041 The Inpatient and Outpatient Antibiotic susceptibility reports and trended data are available online at the Henry intranet website (http//henry.hfhs.org). Type “Antibiograms” in the Search box, then click “go” and follow the link to the Microbiology Division webpage hosting the antibiograms. Links to the reports are on the right side of the page. The reports are posted in PDF format and can be downloaded to your PDA. Downloading instructions are available from the Sladen library webpage . Antibiogram data is for West Bloomfield Hospital use only. Do not print this data except for your own use. Inquiries by pharmaceutical sales representatives or others should be directed to Pharmacy. Pharmacy will release data when appropriate. Form #: WBC-75-0320-0411rev

Transcript of SAMPLE - hfhs-formslibrary.orghfhs-formslibrary.org/forms/WBC-75-0320-0411 antibiotic... ·...

West Bloomfield Hospital Antibiotic Susceptibility Report

2010

Department of Pathology and Laboratory Medicine

West Bloomfield Hospital Pathology Department – Microbiology Division, Antibiotic Susceptibility Report

W. Bloomfield LaboratoryDr. Bruce Jones, MD, Medical Director, 248-325-0509 Debbie Chapman, Operations Manager, 248-325-0508 Microbiology DivisionLinoj Samuel, PhD, D(ABMM), Division Head, 313-916-2341 Robert Tibbetts, PhD, Associate Director, 313-916-9381 Rhonda Hensley, MT(ASCP), Manager, 313-916-1745 Gerald B. Russell, RM(AAM), Leader, Serology/Virology, 313-916-1045 Lucy Avellano, MT(ASCP), Leader, Afternoon Service, 313-916-1041

The Inpatient and Outpatient Antibiotic susceptibility reports and trended data are available online at the Henry intranet website (http//henry.hfhs.org). Type “Antibiograms” in the Search box, then click “go” and follow the link to the Microbiology Division webpage hosting the antibiograms. Links to the reports are on the right side of the page. The reports are posted in PDF format and can be downloaded to your PDA. Downloading instructions are available from the Sladen library webpage.

Antibiogram data is for West Bloomfield Hospital use only. Do not print this data except for your own use. Inquiries by pharmaceutical sales representatives or others should be directed to Pharmacy. Pharmacy will release data when appropriate.

Form #: WBC-75-0320-0411rev

West Bloomfield Hospital Antibiotic Susceptibility Report

2010

Department of Pathology and Laboratory Medicine

West Bloomfield Hospital Pathology Department – Microbiology Division, Antibiotic Susceptibility Report

W. Bloomfield LaboratoryDr. Bruce Jones, MD, Medical Director, 248-325-0509 Debbie Chapman, Operations Manager, 248-325-0508 Microbiology DivisionLinoj Samuel, PhD, D(ABMM), Division Head, 313-916-2341 Robert Tibbetts, PhD, Associate Director, 313-916-9381 Rhonda Hensley, MT(ASCP), Manager, 313-916-1745 Gerald B. Russell, RM(AAM), Leader, Serology/Virology, 313-916-1045 Lucy Avellano, MT(ASCP), Leader, Afternoon Service, 313-916-1041

The Inpatient and Outpatient Antibiotic susceptibility reports and trended data are available online at the Henry intranet website (http//henry.hfhs.org). Type “Antibiograms” in the Search box, then click “go” and follow the link to the Microbiology Division webpage hosting the antibiograms. Links to the reports are on the right side of the page. The reports are posted in PDF format and can be downloaded to your PDA. Downloading instructions are available from the Sladen library webpage.

Antibiogram data is for West Bloomfield Hospital use only. Do not print this data except for your own use. Inquiries by pharmaceutical sales representatives or others should be directed to Pharmacy. Pharmacy will release data when appropriate.

Form #: WBC-75-0320-0411rev

SAMPLE

West Bloomfield Hospital Pathology Department – Microbiology Division, INPATIENT Antibiotic Susceptibility Report Antibiotic

Susceptibility Report INPATIENT

% Susceptible Jan-Dec 2010

Tota

l Stra

ins

Am

pici

llin

Peni

cilli

n

Pip/

Tazo

Met

h/O

x/N

af b

1st G

ener

atio

n C

epha

losp

orin

c

Cef

ipim

e

Cef

triax

one

Imip

enem

Azt

reon

am

Gen

tam

icin

Tobr

amyc

in

Am

ikac

in

Cip

roflo

xaci

n

Van

com

ycin

Eryt

hrom

ycin

Clin

dam

ycin

Trim

etho

prim

/ Su

lfam

etho

xazo

l

Am

pici

llin/

Su

lbac

tam

Enterobacter cloacae 23 0 82 0 100 75h 100 75 100 95 100 86 81 0

Escherichia colia

189 50 94 85 95 93 100 95 92 89 100 70 74 59

Klebsiella oxytocaa 16 0 88 88 94 88 100 88 94 94 100 87 88 88

Klebsiella pneumoniaea 60 0 90 88 95 91 100 88 93 93 98 87 89 83

Proteus mirabilis 29 84 100 92 100 100 100 100 100 100 100 56 59 93

Pseudomonas aeruginosa 82 80d 90 9 81 76 77 86 95 72

Methicillin resistant S.aureus 99 0 0 87 100 9 38e 94

Methicillin susceptible S.aureus 65 25 100 95 100 60 62e 100

Enterococcus faecalis 115 99 89

Enterococcus faecium 34 10 27

a. 15% of Klebsiella pneumoniae, 13% of Klebsiella oxytoca and 9% of E. coli produce extended-spectrum β-lactamase (ESBL) b. β-lactamase-resistant penicillins. HFH formulary agents = Nafcillin (Nafcil) and Dicloxacillin (Dynapen) c. HFH Formulary agent = Cefazolin (Ancef) d. Susceptible ≤ 16mcg/ml e. All staphylococcal isolates tested for inducible clindamycin resistance h. This organism is known to harbor an inducible AmpC beta lactamase and may develop resistance during prolonged therapy with third generation cephalosporins such as ceftriaxone. Antibiogram data is for Henry Ford Health System use only. Do not print this data except for your own use. Inquiries by pharmaceutical

sales representatives or others should be directed to Pharmacy. Pharmacy will release data when appropriate.

West Bloomfield Hospital Pathology Department – Microbiology Division, OUTPATIENT Antibiotic Susceptibility Report Antibiotic

Susceptibility Report OUTPATIENT % Susceptible Jan-Dec 2010

Tota

l Stra

ins

Am

pici

llin

Peni

cilli

n

Met

h/O

x/N

af b

1st G

ener

atio

n C

epha

losp

orin

c

Cef

triax

one

Gen

tam

icin

Cef

epim

e

Tetra

cycl

ine

(D

oxyc

yclin

e)

Cip

roflo

xaci

n

Van

com

ycin

Eryt

hrom

ycin

(A

zith

rom

ycin

, C

larit

hrom

ycin

)

Clin

dam

ycin

Trim

etho

prim

/ Su

lfam

etho

xazo

l

Am

pici

llin/

Su

lbac

tam

Nitr

ofur

anto

in

(Urin

e on

ly)

Citrobacter freundii 14 0 0 92h 100 100 100 79 0 100

Citrobacter koseri 24 0 100 100h 100 100 100 100 100 54

Enterobacter aerogenes 13 0 0 92h 100 100 92 92 0 23

Enterobacter cloacae 34 0 0 85h 97 100 94 94 0 15

Escherichia coli 824 58 92 96 92 96 79 76 68 95

Klebsiella oxytoca 32 0 70 97 97 100 93 97 77 71

Klebsiella pneumoniae 162 0 91 95 94 97 93 89 84 24

Proteus mirabilis 71 78 96 100 94 100 70 75 90

Pseudomonas aeruginosa 85 17 80 92 71

Methicillin resistant S.aureus 116 0 0 90 97 100 8 53e 98 97

Methicillin susceptible S.aureus 102 19 100 97 93 100 63 76e 97 100

Enterococcus faecalis 153 99 22 91 98

Enterococcus faecium 28 7 22 26 19

b. β-lactamase-resistant penicillins. HFH formulary agents = Nafcillin (Nafcil) and Dicloxacillin (Dynapen) c. HFH Formulary agent = Cefazolin (Ancef) e. All Staphylococcal isolates are tested for inducible clindamycin resistance. h. This organism is known to harbor an inducible AmpC beta lactamase and may develop resistance during prolonged therapy with third generation cephalosporins such as ceftriaxone. Antibiogram data is for Henry Ford Health System use only. Do not print this data except for your own use. Inquiries by pharmaceutical

sales representatives or others should be directed to Pharmacy. Pharmacy will release data when appropriate

West Bloomfield Hospital Pathology Department – Microbiology Division, INPATIENT Antibiotic Susceptibility Report Antibiotic

Susceptibility Report INPATIENT

% Susceptible Jan-Dec 2010

Tota

l Stra

ins

Am

pici

llin

Peni

cilli

n

Pip/

Tazo

Met

h/O

x/N

af b

1st G

ener

atio

n C

epha

losp

orin

c

Cef

ipim

e

Cef

triax

one

Imip

enem

Azt

reon

am

Gen

tam

icin

Tobr

amyc

in

Am

ikac

in

Cip

roflo

xaci

n

Van

com

ycin

Eryt

hrom

ycin

Clin

dam

ycin

Trim

etho

prim

/ Su

lfam

etho

xazo

l

Am

pici

llin/

Su

lbac

tam

Enterobacter cloacae 23 0 82 0 100 75h 100 75 100 95 100 86 81 0

Escherichia colia

189 50 94 85 95 93 100 95 92 89 100 70 74 59

Klebsiella oxytocaa 16 0 88 88 94 88 100 88 94 94 100 87 88 88

Klebsiella pneumoniaea 60 0 90 88 95 91 100 88 93 93 98 87 89 83

Proteus mirabilis 29 84 100 92 100 100 100 100 100 100 100 56 59 93

Pseudomonas aeruginosa 82 80d 90 9 81 76 77 86 95 72

Methicillin resistant S.aureus 99 0 0 87 100 9 38e 94

Methicillin susceptible S.aureus 65 25 100 95 100 60 62e 100

Enterococcus faecalis 115 99 89

Enterococcus faecium 34 10 27

a. 15% of Klebsiella pneumoniae, 13% of Klebsiella oxytoca and 9% of E. coli produce extended-spectrum β-lactamase (ESBL) b. β-lactamase-resistant penicillins. HFH formulary agents = Nafcillin (Nafcil) and Dicloxacillin (Dynapen) c. HFH Formulary agent = Cefazolin (Ancef) d. Susceptible ≤ 16mcg/ml e. All staphylococcal isolates tested for inducible clindamycin resistance h. This organism is known to harbor an inducible AmpC beta lactamase and may develop resistance during prolonged therapy with third generation cephalosporins such as ceftriaxone. Antibiogram data is for Henry Ford Health System use only. Do not print this data except for your own use. Inquiries by pharmaceutical

sales representatives or others should be directed to Pharmacy. Pharmacy will release data when appropriate.

West Bloomfield Hospital Pathology Department – Microbiology Division, OUTPATIENT Antibiotic Susceptibility Report Antibiotic

Susceptibility Report OUTPATIENT % Susceptible Jan-Dec 2010

Tota

l Stra

ins

Am

pici

llin

Peni

cilli

n

Met

h/O

x/N

af b

1st G

ener

atio

n C

epha

losp

orin

c

Cef

triax

one

Gen

tam

icin

Cef

epim

e

Tetra

cycl

ine

(D

oxyc

yclin

e)

Cip

roflo

xaci

n

Van

com

ycin

Eryt

hrom

ycin

(A

zith

rom

ycin

, C

larit

hrom

ycin

)

Clin

dam

ycin

Trim

etho

prim

/ Su

lfam

etho

xazo

l

Am

pici

llin/

Su

lbac

tam

Nitr

ofur

anto

in

(Urin

e on

ly)

Citrobacter freundii 14 0 0 92h 100 100 100 79 0 100

Citrobacter koseri 24 0 100 100h 100 100 100 100 100 54

Enterobacter aerogenes 13 0 0 92h 100 100 92 92 0 23

Enterobacter cloacae 34 0 0 85h 97 100 94 94 0 15

Escherichia coli 824 58 92 96 92 96 79 76 68 95

Klebsiella oxytoca 32 0 70 97 97 100 93 97 77 71

Klebsiella pneumoniae 162 0 91 95 94 97 93 89 84 24

Proteus mirabilis 71 78 96 100 94 100 70 75 90

Pseudomonas aeruginosa 85 17 80 92 71

Methicillin resistant S.aureus 116 0 0 90 97 100 8 53e 98 97

Methicillin susceptible S.aureus 102 19 100 97 93 100 63 76e 97 100

Enterococcus faecalis 153 99 22 91 98

Enterococcus faecium 28 7 22 26 19

b. β-lactamase-resistant penicillins. HFH formulary agents = Nafcillin (Nafcil) and Dicloxacillin (Dynapen) c. HFH Formulary agent = Cefazolin (Ancef) e. All Staphylococcal isolates are tested for inducible clindamycin resistance. h. This organism is known to harbor an inducible AmpC beta lactamase and may develop resistance during prolonged therapy with third generation cephalosporins such as ceftriaxone. Antibiogram data is for Henry Ford Health System use only. Do not print this data except for your own use. Inquiries by pharmaceutical

sales representatives or others should be directed to Pharmacy. Pharmacy will release data when appropriate

SAMPLE